Search results
25 cze 2024 · Part 1 of this consensus provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes. Part 2 of this consensus provides an additional overview of the diagnosis and treatment of scleromyxoedema and scleroedema (of Buschke).
8 mar 2024 · The present consensus provides an update to the 2017 European Dermatology Forum Guidelines, focusing on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis.
4 lut 2022 · There is an urgent need for controlled studies to guide the management of CC. Treating RP, keeping hands warm, and avoiding trauma are important preventative measures. Small retrospective, prospective, and case studies have reported varied success with diverse treatments for CC in SSc, which are described below in brief .
scleroderma” or “morphea” should be used for the disease because “localized scleroderma” or “circumscribed scleroderma” might be confused with “systemic scleroderma”, resulting in unnecessary patient concern.
8 mar 2024 · Scleromyxoedema, also known as diffuse/generalized and sclerodermoid lichen myxoedematosus or Arndt-Gottron disease, is a primary cutaneous mucinosis characterized by a generalized, papular and sclerodermoid, cutaneous eruption that usually occurs in association with monoclonal gammopathy. 1 Affected patients develop numerous waxy, firm papules ...
Here, we comprehensively discuss current treatment options for scleroderma, encompassing old, new, and future potential treatment options. In addition, we summarize data from new clinical trials that have the potential to modify the disease process and improve long-term outcomes in SSc.
3 lut 2022 · Systemic sclerosis (SSc), also referred to as systemic scleroderma or scleroderma, is a rare, complex immune-mediated connective tissue disease characterized by progressive skin fibrosis and other clinically heterogenous features.
